Add-on Therapy of EPA Reduces Oxidative Stress and Inhibits the Progression of Aortic Stiffness in Patients with Coronary Artery Disease and Statin Therapy: A Randomized Controlled Study
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
AIM: We examined the anti-oxidant mechanisms of combined therapy of eicosapentaenoic acid (EPA) plus statin on the progression of atherosclerosis. METHODS: Patients receiving statin therapy for dyslipidemia and with coronary artery disease (CAD) were assigned randomly in an open-label manner to the EPA (1,800 mg/day) -plus-statin group (n= 25; combined-therapy group) or to the statin-only group (n= 25), and followed for 48 weeks. At baseline and 48 weeks after enrollment, oxidative stress, brachial-ankle pulse wave velocity (baPWV) and stiffness parameter β-index of the carotid were measured. RESULTS: The lipid profile remained unchanged throughout the study. Although the median value of baPWV increased more in the statin-only group than in the combined-therapy group, this difference was not significant (p= 0.29); however, a decrease in baPWV was associated with combined-therapy treatment by multiple regression analysis adjusted for age and mean blood pressure (p= 0.04). In addition, the β-index of the carotid was lower in the combined-therapy group than in the statin-only group (p= 0.02). Furthermore, although the difference in the reduction of the urinary concentration of 8-isoprostane between the two groups did not reach statistical significance, this concentration was significantly lower in the combined-therapy group with higher baseline levels (≥ 183 pg/mL · Cr) of urinary 8-isoprostane (p= 0.004). CONCLUSIONS: EPA may reduce oxidative stress and inhibit the progression of arterial stiffness more efficiently than statin-only therapy in patients with dyslipidemia and CAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vlachopoulos, C., Aznaouridis, K., O'Rourke, M. F., Safar, M. E., Baou, K., & Stefanadis, C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq024 · Cited by 1,363
Omega-3 polyunsaturated fatty acids and cardiovascular diseases.
Lavie, C. J., Milani, R. V., Mehra, M. R., & Ventura, H. O. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.084 · Cited by 644
Effectiveness of Statin Therapy in Adults With Coronary Heart Disease
Wilt, T. J., Bloomfield, H. E., MacDonald, R., Nelson, D., Rutks, I., Ho, M., Larsen, G., McCall, A., Pineros, S., & Sales, A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1427 · Cited by 275
Research works printed but not linked: 35
- 10.1016/S0140-6736(05)67394-1 · DOI · Paper page
- 3) Sharma RK, Singh VN, Reddy HK: Thinking beyond low-density lipoprotein cholesterol: Strategies to further reduce cardiovascular risk. Vasc Health Risk Manag, 2009; 5: 793-799 · DOI
- 4) Lee JH, O' Keefe JH, Lavie CJ, Harris WS: Omega-3 fatty acids: Cardiovascular benefits, sources and sustainability. Nat Rev Cardiol, 2009; 6: 753-758 · DOI · Paper page
- 5) Jacobson TA: Beyond lipids: The role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease. Curr Atheroscler Rep, 2007; 9: 145-153 · DOI
- 10.1253/circj.CJ-08-1197 · DOI · Paper page
- 10.1016/S0140-6736(07)60527-3 · DOI · Paper page
- 9) Cecelja M, Chowienczyk P: Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: A systematic review. Hypertension, 2009; 54: 1328-1336 · DOI · Paper page
- 10) Inoue N, Maeda R, Kawakami H, Shokawa T, Yamamoto H, Ito C, Sasaki H: Aortic pulse wave velocity predicts cardiovascular mortality in middle-aged and elderly japanese men. Circ J, 2009; 73: 549-553 · DOI
- 10.1161/ATVBAHA.109.196980 · DOI · Paper page
- 10.5551/jat.E605 · DOI
- 10.1016/S0002-9149(02)02226-9 · DOI
- 10.1161/01.CIR.0000015607.33345.1F · doi:10.1161/01.cir.0000015607.33345.1f
- 15) Umeji K, Umemoto S, Itoh S, Tanaka M, Kawahara S, Fukai T, Matsuzaki M: Comparative effects of pitavastatin and probucol on oxidative stress, Cu/Zn superoxide dismutase, PPAR-gamma, and aortic stiffness in hypercholesterolemia. Am J Physiol Heart Circ Physiol, 2006; 291: H2522-2532 · DOI
- 10.1291/hypres.25.359 · DOI · Paper page
- 10.1291/hypres.27.851 · DOI
- 10.1016/S0895-7061(03)00918-X · DOI · Paper page
- 19) Hirai T, Sasayama S, Kawasaki T, Yagi S: Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation, 1989; 80: 78-86 · DOI · Paper page
- 20) O' Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med, 1999; 340: 14-22
- 10.1016/j.jjcc.2008.09.010 · DOI
- 10.1016/0003-2697(84)90467-6 · DOI · Paper page
- 10.1016/0049-3848(84)90248-2 · DOI
- 10.5551/jat.2618 · DOI · Paper page
- 25) Origasa H, Yokoyama M, Matsuzaki M, Saito Y, Matsuzawa Y: Clinical importance of adherence to treatment with eicosapentaenoic acid by patients with hypercholesterolemia. Circ J, 2010; 74: 510-517 · DOI · Paper page
- 10.5551/jat.3616 · DOI
- 27) Wang KL, Cheng HM, Sung SH, Chuang SY, Li CH, Spurgeon HA, Ting CT, Najjar SS, Lakatta EG, Yin FC, Chou P, Chen CH: Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: A community-based study. Hypertension, 2010; 55: 799-805 · DOI · Paper page
- 10.1291/hypres.28.651 · DOI
- 10.1038/hr.2009.145 · DOI
- 10.1161/01.CIR.0000093660.86242.BB · DOI · Paper page
- 10.1161/01.CIR.0000093661.90582.c4 · DOI · Paper page
- 10.1253/jcj.60.691 · DOI
- 33) Hironaka K, Yano M, Kohno M, Tanigawa T, Obayashi M, Konishi M, Umemoto S, Matsuzaki M: In vivo aortic wall characteristics at the early stage of atherosclerosis in rabbits. Am J Physiol, 1997; 273: H1142-1147 · DOI
- 10.1016/S0163-7827(97)00001-5 · DOI · Paper page
- 35) Nakamura N, Hamazaki T, Ohta M, Okuda K, Urakaze M, Sawazaki S, Yamazaki K, Satoh A, Temaru R, Ishikura Y, Takata M, Kishida M, Kobayashi M: Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. Int J Clin Lab Res, 1999; 29: 22-25 · DOI
- 36) Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE: Effect of omega-3 fatty acid supplementation on the arachidonic acid: Eicosapentaenoic acid ratio. Pharmacotherapy, 2007; 27: 633-638 · DOI
- 10.5551/jat.281 · DOI
Cited by
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
Mason, R. P., Libby, P., & Bhatt, D. L. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313286 · Cited by 407
Borow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.035 · Cited by 175
Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)
Brinton, E. A., & Mason, R. P. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0415-8 · Cited by 83
Wang, T., Zhang, X., Zhou, N., Shen, Y., Li, B., Chen, B. E., & Li, X. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029512 · Cited by 73
Mason, R. P., Sherratt, S. C. R., & Jacob, R. F. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000379 · Cited by 72
Metadata
- Authors
- Takaki, A., Umemoto, S., Ono, K., Seki, K., Ryoke, T., Fujii, A., Itagaki, T., Harada, M., Tanaka, M., Yonezawa, T., Ogawa, H., & Matsuzaki, M.
- Venue
- Journal of Atherosclerosis and Thrombosis
- Publisher
- Japan Atherosclerosis Society
- Published
- 2011
- Volume
- 18
- Issue
- 10
- Pages
- 857-866
- ISSN
- 1340-3478 (ISSN-L)
- 1880-3873
- OpenAlex
- W2082820286
- Cited by
- 41
- References
- 3
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Add-on Therapy of EPA Reduces Oxidative Stress and Inhibits the Progression of Aortic Stiffness in Patients with Coronary Artery Disease and Statin Therapy: A Randomized Controlled Study. https://app.cochat.ai/papers/10.5551/jat.7260
- The paper
- Takaki, A., Umemoto, S., Ono, K., Seki, K., Ryoke, T., Fujii, A., Itagaki, T., Harada, M., Tanaka, M., Yonezawa, T., Ogawa, H., & Matsuzaki, M. (2011). Add-on Therapy of EPA Reduces Oxidative Stress and Inhibits the Progression of Aortic Stiffness in Patients with Coronary Artery Disease and Statin Therapy: A Randomized Controlled Study. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.7260
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.